US Broker Ratings

Genmab A/S (GMAB) Stock Analysis: A Biotechnology Powerhouse with 20.77% Upside Potential

Genmab A/S (NASDAQ: GMAB), a frontrunner in the biotechnology sector, is capturing the attention of investors with its robust pipeline of antibody-based cancer treatments and a..

BeOne Medicines Ltd. (ONC): Consensus Signals 25.84% Upside Amid Robust Oncology Pipeline

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is making waves in the healthcare industry with its strong focus on oncology treatments. Headquartered..

Charles River Laboratories (CRL) Stock Analysis: Navigating Challenges with Strategic Collaborations

Charles River Laboratories International, Inc. (NYSE: CRL), a prominent player in the healthcare sector specializing in diagnostics and research, presents a mixed yet intriguing landscape for..

Universal Health Services, Inc. (UHS) Stock Analysis: Unpacking the 13.29% Potential Upside

Universal Health Services, Inc. (NYSE: UHS) stands at a fascinating crossroads for investors interested in the healthcare sector. With a market capitalization of $14.17 billion, UHS..

IQVIA Holdings, Inc. (IQV): Investor Outlook Reveals 12.48% Potential Upside in Healthcare Powerhouse

IQVIA Holdings, Inc. (NYSE: IQV), a leader in the diagnostics and research industry within the broader healthcare sector, is capturing investor attention with strong market fundamentals..

Novartis AG (NVS) Stock Analysis: A Healthcare Giant with a 32.62% ROE and Promising Upside

Novartis AG (NYSE: NVS), a colossal player in the healthcare sector, continues to capture investor attention with its robust performance metrics and strategic focus on innovation...

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 29.76% Potential Upside in Biotechnology

ADMA Biologics Inc. (NASDAQ: ADMA), a key player in the biotechnology sector, is capturing the attention of investors with its innovative approach to treating immune deficiencies..

Grifols, S.A. (GRFS) Investor Outlook: Unpacking Potential Upside of Over 21%

Grifols, S.A. (NASDAQ: GRFS), a stalwart in the healthcare sector, particularly within the drug manufacturing industry, is capturing investor attention with a significant potential upside of..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating a Potential 3.46% Downside in a Volatile Healthcare Sector

Medpace Holdings, Inc. (NASDAQ: MEDP) has carved a niche in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Cincinnati, Ohio, Medpace offers..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare Growth with a Solid Dividend Yield

Teleflex Incorporated (NYSE: TFX), a stalwart in the healthcare sector, is known for its innovative medical devices that cater to critical care and surgical applications. With..

Quest Diagnostics (DGX) Stock Analysis: Navigating a Promising 8% Upside in Healthcare Diagnostics

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the Healthcare sector specializing in Diagnostics & Research, presents an intriguing opportunity for investors looking to capitalize..

Qiagen N.V. (QGEN) Investor Outlook: Assessing the 11.52% Potential Upside

For investors eager to explore opportunities within the healthcare sector, Qiagen N.V. (NASDAQ: QGEN) presents a compelling case. As a leading player in the diagnostics and..

Becton, Dickinson and Company (BDX) Stock Analysis: Insights into a Healthcare Giant’s 1.05% Potential Upside

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, commands a significant presence in the medical instruments and supplies industry. With a market..

Ionis Pharmaceuticals (IONS) Stock Analysis: A Strategic Biotech with 6.17% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a prominent player in the biotechnology sector, is capturing investor attention with its strategic focus on RNA-targeted medicines. With a market..

Legend Biotech Corporation (LEGN) Stock Analysis: A Potential 223.95% Upside with Promising CAR-T Therapy Innovations

Legend Biotech Corporation (NASDAQ: LEGN) presents an intriguing opportunity for investors within the healthcare sector, particularly those with an interest in biopharmaceutical innovations. With a market..

Bruker Corporation (BRKR) Investor Outlook: Analyzing a 10.16% Potential Upside

Bruker Corporation (NASDAQ: BRKR) is a prominent player in the healthcare sector, specifically within the medical devices industry. With its headquarters in Billerica, Massachusetts, Bruker has..

Summit Therapeutics Inc. (SMMT) Investor Outlook: A Biotech Play with 84.83% Potential Upside

Summit Therapeutics Inc. (NASDAQ: SMMT), with a market cap of $13.08 billion, presents a compelling opportunity for investors seeking exposure in the healthcare sector, specifically within..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a 3.37% Potential Upside in the Healthcare Sector

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, has long been a name synonymous with innovation and quality in the pharmaceutical..

Danaher Corporation (DHR) Stock Analysis: Exploring a 13.15% Potential Upside and Robust Buy Ratings

Danaher Corporation (NYSE: DHR), a titan in the healthcare sector, operates at the forefront of diagnostics and research. With a market capitalization of $162.06 billion, Danaher..

Globus Medical, Inc. (GMED) Stock Analysis: Strong Revenue Growth and Promising Upside Potential

Globus Medical, Inc. (NYSE: GMED), a leader in the medical devices sector, is capturing the attention of investors with its robust revenue growth and promising stock..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds